Search All News
An NIH award will help fund a collaborative effort of Columbia University's Department of Pediatrics and Department of Psychiatry titled Prospective Genetic Risk Evaluation and Assessment in Autism.
Columbia Psychiatry study paves the way for treatment techniques to help people adapt to the loss of a loved one.
Columbia psychiatrist Nasir Naqvi, MD, PhD, discusses which treatments for alcohol use disorder are most effective and the importance of community and support in treating AUD.
A longstanding NYP-Columbia program has been at the forefront of embedding behavioral health clinics in public schools.
Source:Huffington PostOctober 3, 2018
“I think she’d need to assume that anything actually provided to the senators would no longer be confidential,” Dr. Paul Appelbaum said regarding Christine Blasey Ford.
- October 2, 2018
The team at the Columbia Gambling Disorders Clinic applies the principles of Cognitive Behavioral Therapy (CBT), an evidence-based approach to treating addictive behaviors.
Source:CU Boulder TodayOctober 2, 2018
“Close attachments contribute importantly to many of the psychological problems individuals face,” says Dr. Katherine Shear.
- October 1, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have identified the blockade which improves not only the side effect profile but also the therapeutic impact of SSRIs.
Source:Teen VogueSeptember 28, 2018
Dr. Yuval Neria said her fear is what made Ford’s description of the assault so clear compared to other events of the day.
Source:LaddersSeptember 28, 2018
“I’m a pill pusher for a living, and it still appeals to me to do something that doesn’t involve pills,” says Dr. Jonathan Stewart.
Source:Raw StorySeptember 26, 2018
Dr. Carl Hart discusses opioid use.
Source:Military TimesSeptember 26, 2018
The digital program GriefSteps is based on a model of grief therapy developed by Dr. Katherine Shear that has been used with people with complicated grief to help with successful adaptation to loss.
Source:MD MagazineSeptember 26, 2018
“It’s unlikely that there will be new effort placed on developing newer, better, medications because fewer people will be affected by this,” said Dr. Jeffrey Lieberman.